A chronic model of arthritis supported by a strain-specific periarticular lymph node in BALB/c mice

Nature Communications

Volumn 4, Issue , 2013, Pages

  Baddack, Uta ^a   Hartmann, Sven ^a   Bang, Holger ^b   Grobe, Jenny ^a   Loddenkemper, Christoph ^c   Lipp, Martin ^a   Müller, Gerd ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b ORGENTEC Diagnostika GmbH   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; COLLAGEN; PEPTIDE ANTIBODY;

ANTIBODY; ANTIGEN; COMPLEXITY; PATHOGENICITY; PATHOLOGY; PEPTIDE; RODENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHROPATHY; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; KNEE; LYMPH NODE; MOUSE; NONHUMAN; PATHOGENESIS; RHEUMATOID ARTHRITIS; SYNOVIUM;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; LYMPH NODES; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES;

EID: 84877731362     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2625     Document Type: Article

References (47)

1. Firestein, G. S. Evolving concepts of rheumatoid arthritis. Nature 423, 356-361 (2003). (Pubitemid 40852711)
2. Schellekens, G. A. et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 43, 155-163 (2000). (Pubitemid 30368225)
3. Van Gaalen, F. A. et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum. 50, 709-715 (2004). (Pubitemid 38326168)
4. Nielen, M. M. J. et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 50, 380-386 (2004). (Pubitemid 38198821)
5. Rantapää-Dahlqvist, S. et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 48, 2741-2749 (2003). (Pubitemid 37280601)
6. Kroot, E. J. et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 43, 1831-1835 (2000).
7. Van Gaalen, F. A. et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum. 50, 2113-2121 (2004). (Pubitemid 38924388)
8. Huizinga, T. W. et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum. 52, 3433-3438 (2005). (Pubitemid 41612209)
9. Brackertz, D., Mitchell, G. F. & Mackay, I. R. Antigen-induced arthritis in mice. Arthritis Rheum. 20, 841-850 (1977).
10. Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A. & Mosedale, B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283, 666-668 (1980). (Pubitemid 10099994)
11. Cope, A. T cells in rheumatoid arthritis. Arthritis Res. Ther. 10, S1 (2008).
12. Bang, H. et al. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum. 56, 2503-2511 (2007). (Pubitemid 47237269)
13. Baschant, U. et al. Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells. Proc. Natl Acad. Sci. USA 108, 19317-19322 (2011).
14. Irmler, I. M., Gajda, M. & Bräuer, R. Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J. Immunol. 179, 6228-6236 (2007).
15. Asquith, D. L., Miller, A. M., McInnes, I. B. & Liew, F. Y. Animal models of rheumatoid arthritis. Eur. J. Immunol. 39, 2040-2044 (2009).
16. Lindqvist, A.-K. B. et al. Mouse models for rheumatoid arthritis. Trends Genet. 18, S7-S13 (2002). (Pubitemid 34607124)
17. Luross, J. A. & Williams, N. A. The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology 103, 407-416 (2001). (Pubitemid 32744386)
18. Bevaart, L., Vervoordeldonk, M. J. & Tak, P. P. Collagen-induced arthritis in mice. in Mouse Models for Drug Discovery: Methods and Protocols, Vol. 602 (eds Proetzel, G. & Wiles, M. V.) 181-192 (Humana, 2010).
19. Campbell, I. K., Hamilton, J. A. & Wicks, J. A. Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur. J. Immunol. 30, 1568-1575 (2000). (Pubitemid 30342798)
20. Bäckström, N. F. & Dahlgren, U. I. H. Induction of experimental arthritis in Balb/C Mice by inclusion of a foreign protein in the collagen inoculum. Scand. J. Immunol. 67, 322-328 (2008). (Pubitemid 351392918)
21. Cook, A. D., Rowley, M. J., Mackay, I. R., Gough, A. & Emery, P. Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression. Arthritis Rheum. 39, 1720-1727 (1996). (Pubitemid 26331026)
22. Ronnelid, J., Lysholm, J., Engstrom-Laurent, A., Klareskog, L. & Heyman, B. Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum. 37, 1023-1029 (1994). (Pubitemid 24222093)
23. Kleinau, S., Martinsson, P. & Heyman, B. Induction and suppression of collagen-induced arthritis is dependent on distinct Fcg receptors. J. Exp. Med. 191, 1611-1616 (2000). (Pubitemid 30257357)
24. Van de Velde, N. C. et al. Transgenic mice expressing human FcgammaRIIa have enhanced sensitivity to induced autoimmune arthritis as well as elevated Th17 cells. Immunol. Lett. 130, 82-88 (2010).
25. Wang, Y. et al. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J. Immunol. 164, 4340-4347 (2000). (Pubitemid 30215097)
26. Baeten, D. et al. Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum. 44, 2255-2262 (2001). (Pubitemid 32977493)
27. Van Venrooij, W. J., van Beers, J. J. & Pruijn, G. J. Anti-CCP antibodies: the past, the present and the future. Nat. Rev. Rheumatol. 7, 391-398 (2011).
28. Avouac, J., Gossec, L. & Dougados, M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann. Rheum. Dis. 65, 845-851 (2006).
29. Li, H. et al. Diagnostic value of anti-cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity. Clin. Rheumatol. 29, 413-417 (2010).
30. Van Gaalen, F. A., Visser, H. & Huizinga, T. W. A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis. Ann. Rheum. Dis. 64, 1510-1512 (2005). (Pubitemid 41623868)
31. Imboden, J. B. The immunopathogenesis of rheumatoid arthritis. Annu. Rev. Pathol. 4, 417-434 (2009).
32. Klareskog, L., Ronnelid, J., Lundberg, K., Padyukov, L. & Alfredsson, L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 26, 651-675 (2008). (Pubitemid 351600388)
33. Klareskog, L., Widhe, M., Hermansson, M. & Ronnelid, J. Antibodies to citrullinated proteins in arthritis: pathology and promise. Curr. Opin. Rheumatol. 20, 300-305 (2008). (Pubitemid 351483320)
34. Balsa, A. et al. Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor. Arthritis Res. Ther. 12, R62 (2010).
35. Gyetvai, A. et al. New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies. Rheumatology 49, 25-33 (2010).
36. Kuhn, K. A. et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J. Clin. Invest. 116, 961-973 (2006).
37. Van Gaalen, F., Ioan-Facsinay, A., Huizinga, T. W. & Toes, R. E. The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis. J. Immunol. 175, 5575-5580 (2005). (Pubitemid 41508033)
38. Kidd, B. A. et al. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res. Ther. 10, R119 (2008).
39. Syversen, S. W. et al. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann. Rheum. Dis. 69, 345-351 (2010).
40. Wagner, E., Skoumal, M., Bayer, P. M. & Klaushofer, K. Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis. Rheumatol. Int. 29, 1315-1321 (2009).
41. Nicaise-Roland, P. et al. Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy. Arthritis Res. Ther. 10, R142 (2008).
42. Lundberg, K. et al. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res. Ther. 7, R458-R467 (2005).
43. Humby, F. et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med. 6, e1 (2009).
44. Manzo, A., Bombardieri, M., Humby, F. & Pitzalis, C. Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling. Immunol. Rev. 233, 267-285 (2010).
45. Wengner, A. M. et al. CXCR5-and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis. Arthritis Rheum. 56, 3271-3283 (2007). (Pubitemid 47585423)
46. Mandik-Nayak, L. & Allen, P. M. Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritis. Immunol. Res. 32, 5-13 (2005). (Pubitemid 41153610)
47. Mandik-Nayak, L., Wipke, B. T., Shih, F. F., Unanue, E. R. & Allen, P. M. Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node. Proc. Natl Acad. Sci. USA 99, 14368-14373 (2002). (Pubitemid 35257678)